Hottest Stocks
(Over $10)
Hottest Stocks
($2-$10)
Biggest Losers
(Over $10)
Biggest Losers
($2-$10)
Hottest
Industries
Hottest
Sectors
EPS / Sales
Surprises
 
Enter Ticker Symbol:   Ticker Lookup
 

Enter any portion of the company’s name to find its corresponding ticker symbol:
Search for :   

Zacks Company Profile for United Health Products, Inc. (UEEC : OTC)
 
 • Company Description   
United Health Products, Inc. develop, manufactures and markets patented hemostatic gauze, for the healthcare and wound care sectors. The product, HemoStyp(R), is derived from regenerated oxidized cellulose, which is all natural and designed to absorb exudate/drainage from superficial wounds and control bleeding. It serves dental and medical markets. United Health Products, Inc. is based in Henderson, Nevada.

Number of Employees: 7

 
 • Price / Volume Information   
Yesterday's Closing Price: $0.56 Daily Weekly Monthly
20 Day Moving Average: 148,004 shares
Shares Outstanding: 230.08 (millions)
Market Capitalization: $128.84 (millions)
Beta: -0.81
52 Week High: $1.25
52 Week Low: $0.35
Short Interest Ratio:
  % Price Change % Price Change Relative to S&P 500
4 Week 16.67% 31.39%
12 Week 19.15% 30.98%
Year To Date -5.08% 23.20%
 
 • Address & Contact Information
Street Address Phone / Fax Email Address Web URL
10624 S. EASTERN AVE. SUITE A209
-
HENDERSON,NV 89052
USA
ph: 877-358-3444
fax: -
p.niemetz@panconsultants.com http://www.unitedhealthproductsinc.com
 
 • General Corporate Information   
Officers
Brian Thom - Chief Executive Officer; and Director
Kristofer Heaton - Vice President of Finance and Principal Financial
Robert Denser - Director
Louis Schiliro - Director
Robert Denser - Director

Peer Information
United Health Products, Inc. (BJCT)
United Health Products, Inc. (CADMQ)
United Health Products, Inc. (APNO)
United Health Products, Inc. (UPDC)
United Health Products, Inc. (IMTIQ)
United Health Products, Inc. (CYGN)
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: MED PRODUCTS
Sector: Medical
CUSIP: 91059D100
SIC: 3842
Fiscal Year
Fiscal Year End: December
Last Reported Quarter: 12/01/21
Next Expected EPS Date: 05/25/22
Share - Related Items
Shares Outstanding: 230.08
Most Recent Split Date: (:1)
Beta: -0.81
Market Capitalization: $128.84 (millions)
 
 
 • EPS Information     • Dividend Information
Analyst Coverage: No Dividend Yield: 0.00%
Current Fiscal Quarter EPS Consensus Estimate: $ Indicated Annual Dividend: $0.00
Current Fiscal Year EPS Consensus Estimate: $ Payout Ratio:
Number of Estimates in the Fiscal Year Consensus: Change In Payout Ratio:
Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00
Next EPS Report Date: 05/25/22  
 

 • Fundamental Ratios
P/E
Current FY Estimate: -
Trailing 12 Months: -
PEG Ratio: -
Price Ratios
Price/Book: -
Price/Cash Flow: -
Price / Sales: -
EPS Growth
vs. Year Ago Period: 66.67%
vs. Previous Quarter: -%
Sales Growth
vs. Year Ago Period: -%
vs. Previous Quarter: -%
ROE
03/31/22 - -
12/31/21 - -
09/30/21 - -
ROA
03/31/22 - -2,849.52
12/31/21 - -12,912.20
09/30/21 - -12,052.82
Current Ratio
03/31/22 - 0.02
12/31/21 - 0.02
09/30/21 - 0.19
Quick Ratio
03/31/22 - -
12/31/21 - 0.02
09/30/21 - 0.13
Operating Margin
03/31/22 - -
12/31/21 - -
09/30/21 - -
Net Margin
03/31/22 - -
12/31/21 - -
09/30/21 - -
Pre-Tax Margin
03/31/22 - -
12/31/21 - -
09/30/21 - -
Book Value
03/31/22 - -0.01
12/31/21 - 0.00
09/30/21 - 0.00
Inventory Turnover
03/31/22 - 0.00
12/31/21 - 0.00
09/30/21 - 0.00
Debt-to-Equity
03/31/22 - -
12/31/21 - -
09/30/21 - -
Debt-to-Capital
03/31/22 - -
12/31/21 - -
09/30/21 - -
 

Powered by Zacks Investment Research ©